BCMA-directed therapy for early relapsed and/or refractory multiple myeloma. | Nat Rev Clin Oncol;2024 Jul 19. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

BCMA-directed therapy for early relapsed and/or refractory multiple myeloma.

van de Donk, Niels W C J; Zweegman, Sonja.

Affiliation

van de Donk NWCJ; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands. n.vandedonk@amsterdamumc.nl.
Zweegman S; Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, Netherlands. n.vandedonk@amsterdamumc.nl.

Nat Rev Clin Oncol ; 2024 Jul 19.

Article in En | MEDLINE | ID: mdl-39030279

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Rev Clin Oncol Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Rev Clin Oncol Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: